Advisors
VIA is proud to work with the world’s leading experts in cardiovascular disease.
Clinical Advisors
Marc Pfeffer, M.D., PhD
Dzau Professor of Medicine, Harvard Medical School
Senior Physician, Brigham & Women’s Hospital in Boston
Jean-Claude Tardif, MD
Associate Professor of Medicine, University of Montreal
Director of Research, Montreal Heart Institute
Marcelo Di Carli, MD
Associate Professor of Radiology, and
Chief of Nuclear Medicine, Brigham and Women’s Hospital
Robert Fenichel, MD, PhD
Former Deputy Division Director,
Division of CardioRenal Drug Products, Food and Drug Administration
Peter Libby, MD
Mallinckrodt Professor of Medicine, and
Chief, Cardiovascular Division, Brigham and Women’s Hospital
Jean-Lucien Rouleau, MD
Dean, Faculty of Medicine, University of Montreal
Drug Assessment Advisors
Alex Giaquinto, PhD, Regulatory
Formerly Senior VP Worldwide Director of Regulatory Affairs, Schering-Plough
Felix de la Iglesia, MD, Toxicology, Product Development
Formerly VP Worldwide Pre-Clinical Safety, Warner Lambert
Peter Myers, PhD, Chemistry, Product Development
Formerly VP Chemistry Research, Glaxo
Leonard Post, PhD, Drug Discovery, Research & Development
Formerly VP Discovery, Parke-Davis
Scientific Advisors
Thomas Quertermous, MD, FACC Vascular pathophysiology, genetic and molecular mechanisms of inflammation and atherogenesis
Chief Scientific Officer, Chair of Scientific Advisory Board
Israel Charo, MD, PhD, Inflammatory pathways in atherosclerosis, chemokines
Associate Director, Gladstone Institute of Cardiovascular Disease, University of California, San Francisco
Marco Conti, MD, Role and regulation of phosphodiesterases in inflammation and atherosclerosis
Professor of Obstetrics & Gynecology, Stanford University School of Medicine
Garret Fitzgerald, MD, Cardiovascular biology and pharmacology
Professor of Medicine and Chair, Dept. of Pharmacology, University of Pennsylvania School of Medicine
Colin Funk, PhD, Leukotrienes and lipoxygenase in inflammation and atherosclerosis
Professor, Department of Biochemistry & Physiology, Queens University, Canada
Christopher Glass, MD, PhD, Regulation of macrophage gene expression, including macrophage-specific genes involved in atherosclerosis
Professor, Cellular and Molecular Medicine, University of California, San Diego
Tod Klinger, PhD, Genomic analysis and bioinformatics
Vice President, Information Sciences, XDx, Inc.
Donald H. Maurice, PhD, Phosphodiesterase pharmacology and pathways in cardiovascular disease
Professor, Department of Pharmacology & Toxicology, Queens University, Canada